Showing results (691-700 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|June 9, 2012
Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine researchMartin A Kennedy, Peter R Joyce, Evan J BeggPharmacogenomics|June 9, 2012
Next-generation sequencing and large genome assembliesJoseph Henson, German Tischler, Zemin NingPharmacogenomics|September 5, 2015
The epigenome, 4D nucleome and next-generation neuropsychiatric pharmacogenomicsGerald A Higgins, Ari Allyn-Feuer, Samuel Handelman, et al.Pharmacogenomics|January 23, 2016
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclinesDaniel L Hertz, Megan V Caram, Kelley M Kidwell, et al.Pharmacogenomics|May 17, 2016
Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Xiu Hue Lee, et al.Pharmacogenomics|May 17, 2016
Multilevel models improve precision and speed of IC50 estimatesDaniel J Vis, Lorenzo Bombardelli, Howard Lightfoot, et al.Pharmacogenomics|May 17, 2016
Predictive role of host constitutive variants in neoadjuvant therapy of esophageal cancerEnrica Rumiato, Elisa Boldrin, Alberto Amadori, et al.Pharmacogenomics|March 30, 2016
Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: a systematic reviewLilla M Roy, Richard M Zur, Elizabeth Uleryk, et al.Pharmacogenomics|March 30, 2016
Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method studyDru Riddle, Mat Gregoski, Kathy Baker, et al.Pharmacogenomics|March 30, 2016
Navigating pleiotropy in precision medicine: pharmacogenes from trauma to behavioral healthVicki Oberg, Jerome Differding, Morgan Fisher, et al.Pageof 274